The association held even among those who exercised, and was stronger in people with the APOE-e4 gene. Reducing sitting time may be key to lowering Alzheimer’s risk, especially in genetically ...

When treated with anti-amyloid monoclonal antibodies, as one of the therapeutic options, Alzheimer’s patients with two copies of APOE E4 may experience severe side effects, such as brain swelling or ...

Treatment with lecanemab infusion was safe and generally well-tolerated within an outpatient memory clinic setting, with few infusion-related reactions and a low number of withdrawals due to adverse ...